The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
We did better of a fake Meduflow brochure and an ODX rns last week :)
I suppose its the time scales but long term this is such an amazing company to be invested in....
I've given up trying to predict the RNS implications on the SP. Seriously expected more than a tickle off this mornings news but there you go!
Still several hours of trading to go and therefore plenty time for new buyers/investors to get in and not worry too much about buying on an early opening spike.
and the US will arrive at 14.30....
If this news is so good why, when I look at the share trades, do I see almost nothing but red?
‘If this news is so good why, when I look at the share trades, do I see almost nothing but red? ‘
Because most PIs on AIM have microscopic horizons and probably need the money for Black Friday Xmas presents.
This share will be an absolute monster multi bagger from £1.20 but it could be years before this happens. The quicker we get away from AIM the better.
because traders are off to GDR they don't want to wait till 2022
Probably to both gdr & ncyt. The volume traded on both far exceeds the daily average. Ncyt
sp has been all over the place. Looks like traders playing ping pong.
MM filling orders.....anyone saw the 73,000 buy going in?
Drop was to collect shares from NOVIC holders!
GDR/NCYT are both overbought. It will drop back this week!
Whereas, as usual, Avacta will drop back from it's small increase by the end of today!
Are you always this depressing Russell?
Ive heard the only time Russell is happy is when he is stamping on snails or talking to fridge magnets. Just a rumour mind but does explain a lot.....
Yep leaves is consistently negative except at a funeral where he is in his element.
Donald,
It could be the muted reaction to the SP is due to... "so what" ..... heres an analogy:
Man City are expected to win the league, so when they beat Norwich, its a given to do that if they are going to go on and win the league:
Ergo, if AVCT are going to go on and be successful with AVA600k then this is just a step that is at the early stages of getting to the final goal.
(we need to remember there is still a lot of expectation already reflected in the SP)
Comparing Avactas progress to Man City winning the league is somewhat far fetched.
Man City have a history of winning the league and have huge resources to get themselves there.
Avacta don't and I expect aren't priced on a par like man City winning the league.
Agree...
1. We are going to fill paperwork for FDA in the near term
2. FDA Approved go ahead.
Formality, everything is reading between the lines until Avacta actually tell us how AVA6k is performing. Having been in this share 18months, Ill refrain from being exciting on this news.
PK Data and HUA more important updates in my opinion.
LDA, if you don't like analogy's then try this:
AVCT are losing £20m per year and have valuation of over £300m
AVA better be successful, so currently they are climbing Everest and they have left base camp and proceeding to the first level on the mountain (any better?)
All the steps have to be completed for a successful outcome and the clock is ticking.
That’s assuming they sell no tests during a pandemic, which is very negative thinking imo
my Affidx purchase alone was £175. Surprised there was no RNS today ...
Avacta are already selling test though aren’t they? We just don’t understand the volume yet.
Well, icecool, we are back to negative and positive are we, rather than reality?
What happened to mologic giving tests to poor and middle income countries. You would have thought with this latest outbreak in Africa that that was an opportunity missed?
Given we have had the test out for nearly 6 months and also remember that AS was talking about partners and manufacturing back in the early part of the year to be put in place to hit the ground running, remember also that the test was ready to go 9 months ago and was just waiting for the paperwork (ie CE validation) to be granted.
Then we had Delta, and AVCT could detect it, and still no HUA or EA from anywhere, so even if AVCT detect this variant, I don't see particularly why that will change anything,
It is not negative or positive to think about whether we will get meaningful test sales, but prudent in valuation terms to dismiss it until something concrete emerges, based on the actual evidence.
The writing has been on the wall since July
@Timster “my Affidx purchase alone was £175. Surprised there was no RNS today ...”
If only you suffered from repetitive behaviour in the same way as Marik, they could have RNS’d it
Doc, why then is the SP where it is? Whats your reasoning as to why we are, give or take just above the placing price of 18 months ago?
Why is it that generally covid test related companies SP are on the way down yet Covid treatment companies (SYN for instance) are on the way up, even though Europe , US and UK have high or relatively high infection rates?
I bet if you'd bought your tests from ODX they'd have RNS'd it Timster.
Actually that gives me a great idea!
Why don't you buy more tests this time from them
They do an RNS
We go up
What could possibly go wrong?
That's a muxh better analogy, Wyndrum. Well done!
Let's hope the Avacta team are wrapped up warm. Gets a bit chilly up Everest.